Literature DB >> 12802765

Successful treatment of coccidioidal meningitis with voriconazole.

Karoll J Cortez1, Thomas J Walsh, John E Bennett.   

Abstract

A previously healthy 47-year-old man with coccidioidal meningitis had fluconazole treatment failure and developed severe symptoms, multiple cranial nerve palsies, and brain-stem inflammation visible on magnetic resonance imaging (MRI). High-dose voriconazole therapy resulted in gradual resolution of almost all signs and symptoms, normalization of cerebrospinal fluid, and clearing of brain-stem edema seen on MRI. The patient had photosensitivity after 10 weeks of treatment, but this improved when the voriconazole dose was lowered. Continuous voriconazole therapy kept coccidioidal meningitis in complete remission in this patient for >2 years.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12802765     DOI: 10.1086/375235

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Successful use of voriconazole for treatment of Coccidioides meningitis.

Authors:  Laurie A Proia; Allan R Tenorio
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

3.  Long-term voriconazole and skin cancer: is there cause for concern?

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 4.  New facets of antifungal therapy.

Authors:  Ya-Lin Chang; Shang-Jie Yu; Joseph Heitman; Melanie Wellington; Ying-Lien Chen
Journal:  Virulence       Date:  2016-11-07       Impact factor: 5.882

5.  Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.

Authors:  Suresh J Antony; Peter Jurczyk; Lisa Brumble
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

Review 6.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

7.  Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.

Authors:  Brady J Hurtgen; Natalia Castro-Lopez; Maria Del Pilar Jiménez-Alzate; Garry T Cole; Chiung-Yu Hung
Journal:  Vaccine       Date:  2016-09-09       Impact factor: 3.641

Review 8.  Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

Authors:  Helen W Boucher; Andreas H Groll; Christine C Chiou; Thomas J Walsh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Voriconazole use for endemic fungal infections.

Authors:  Alison Freifeld; Laurie Proia; David Andes; Larry M Baddour; Janis Blair; Brad Spellberg; Sandra Arnold; Arnold Lentnek; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

10.  Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.

Authors:  Asha R Patel; Maria L Turner; Kristin Baird; Juan Gea-Banacloche; Sandra Mitchell; Steven Z Pavletic; Barbara Wise; Edward W Cowen
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.